These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 8735621
1. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats. Gué M, Junien JL, Reeve JR, Rivier J, Grandt D, Taché Y. Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621 [Abstract] [Full Text] [Related]
9. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Souli A, Chariot J, Voisin T, Presset O, Tsocas A, Balasubramaniam A, Laburthe M, Rozé C. Peptides; 1997 Feb; 18(4):551-7. PubMed ID: 9210175 [Abstract] [Full Text] [Related]
10. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors. Widdowson PS, Buckingham R, Williams G. Brain Res; 1997 Dec 05; 778(1):242-50. PubMed ID: 9462897 [Abstract] [Full Text] [Related]
11. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor. Haynes JM, Hill SJ, Selbie LA. Br J Pharmacol; 1997 Dec 05; 122(7):1530-6. PubMed ID: 9421306 [Abstract] [Full Text] [Related]
13. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Chen CH, Stephens RL, Rogers RC. Neurogastroenterol Motil; 1997 Jun 05; 9(2):109-16. PubMed ID: 9198086 [Abstract] [Full Text] [Related]
14. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type. Dumont Y, Cadieux A, Pheng LH, Fournier A, St-Pierre S, Quirion R. Brain Res Mol Brain Res; 1994 Oct 05; 26(1-2):320-4. PubMed ID: 7854062 [Abstract] [Full Text] [Related]
15. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors. Tebbe JJ, Mronga S, Schäfer MK, Rüter J, Kobelt P, Mönnikes H. Am J Physiol Gastrointest Liver Physiol; 2003 Dec 05; 285(6):G1075-83. PubMed ID: 12855401 [Abstract] [Full Text] [Related]
16. Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors. Teyssen S, Grandt D, Niebergall-Roth E, Schimiczek M, Goebell H, Eysselein VE, Reeve JR, Singer MV. Pancreas; 1996 Jul 05; 13(1):80-8. PubMed ID: 8783338 [Abstract] [Full Text] [Related]
17. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Bischoff A, Avramidis P, Erdbrügger W, Münter K, Michel MC. Br J Pharmacol; 1997 Apr 05; 120(7):1335-43. PubMed ID: 9105710 [Abstract] [Full Text] [Related]
18. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells. Grundemar L, Håkanson R. Br J Pharmacol; 1991 Dec 05; 104(4):776-8. PubMed ID: 1725763 [Abstract] [Full Text] [Related]
19. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor. Monnet FP, Fournier A, Debonnel G, de Montigny C. J Pharmacol Exp Ther; 1992 Dec 05; 263(3):1212-8. PubMed ID: 1469629 [Abstract] [Full Text] [Related]
20. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain. Widdowson PS. Brain Res; 1993 Dec 17; 631(1):27-38. PubMed ID: 8298993 [Abstract] [Full Text] [Related] Page: [Next] [New Search]